TPG related stories
All articles and analysis
Corsair eyes finish line for fundraiseThe financial services-specialist has collected more than $900m but will need an additional fundraising extension from LPs to get to its $1.5bn target.
- TPG inks $1.9bn pharma take-private
The firm's buyout group will acquire listed pharmaceutical company Par Pharmaceutical. TPG also has investments in several pharmaceutical companies through its TPG Biotech portfolio.
- PE, VC execs give millions to Romney 'super PAC'
Seventy one individuals from firms including KKR and TPG have donated more than $8.2m to an independent committee dedicated to helping Mitt Romney win the US presidential election.
- Private equity represents second-largest alternatives pool
Private equity represents the second-largest segment within the alternative asset class behind real estate, according to a survey of the world’s top 100 alternatives managers - who together manage $3,136 billion.
- AXA Private Equity buys $850m OMERS portfolio
The transaction comes as OMERS works to reduce its private equity fund commitment business and focus on direct investments.
- GIC and KIA buy into CVC management vehicle
Two sovereign wealth funds, GIC and KIA, and a third unnamed fund have acquired a 10% stake in CVC Capital Partners in a deal which will see them given preferential access to deals as well as a share of management fees and carried interest.
- Turkish private equity must deliver proof of concept
Strong fundamentals alone are not enough to make global LPs bet big on Turkey’s burgeoning economy.
- New York to investigate PE firms over tax abuse
Many of the largest US private equity firms have reportedly been caught up in a probe over management fee conversions, which can reduce the tax they pay by up to 20 percent.
- TPG scores exit with $1.2bn Bayer deal
The sale of vitamin maker Schiff is expected to produce a healthy return for TPG's growth arm, which helped to bring in a new management team and led two add-on acquisitions.
- TPG Credit closes distressed fund above target
The firm, in which TPG Capital owns a 5% stake, beat its $800m target and closed on $997m. The fund is one of a number of distressed vehicles focusing on opportunities in both the US and Europe.